 |
|
|
|
|
|
|
|
 |
 |
|
|
|
|
|
|
| |
Project |
Name |
Target |
Stage |
| Oncolytic Virus |
OBP-301 |
Telomelysin®
|
Head and neck cancer, Hepatocellar carcinoma, esophageal cancer |
Phase I(USA) |
| OBP-401 |
TelomeScan®
(Telomelysin-GFP) |
In vitro cancer diagnosis
Navigation surgery |
Preclinical |
| RNAi |
OBP-701
(TT-033) |
shRNAi |
HCV |
Preclinical |
Small
Molecule |
OBP-601 |
Festinavir® |
HIV infection |
Phase I(USA/EU) |
| HCV/HIV |
Low-molecular compounds |
HCV, dengue fever, HIV |
Screening |
| Molecular target |
INK4 family,
p51 promoter
DR5 promoter |
Lung cancer, Colon cancer, Renal cancer |
Screening |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright
(c)2004-2005, Oncolys BioPharma Inc. All rights reserved.
|
|
